Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

18 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Zebrafish Avatar-test forecasts clinical response to chemotherapy in patients with colorectal cancer.
Costa B, Estrada MF, Gomes A, Fernandez LM, Azevedo JM, Póvoa V, Fontes M, Alves A, Galzerano A, Castillo-Martin M, Herrando I, Brandão S, Carneiro C, Nunes V, Carvalho C, Parvaiz A, Marreiros A, Fior R. Costa B, et al. Among authors: povoa v. Nat Commun. 2024 Jun 5;15(1):4771. doi: 10.1038/s41467-024-49051-0. Nat Commun. 2024. PMID: 38839755 Free PMC article.
Object detection for automatic cancer cell counting in zebrafish xenografts.
Albuquerque C, Vanneschi L, Henriques R, Castelli M, Póvoa V, Fior R, Papanikolaou N. Albuquerque C, et al. Among authors: povoa v. PLoS One. 2021 Nov 29;16(11):e0260609. doi: 10.1371/journal.pone.0260609. eCollection 2021. PLoS One. 2021. PMID: 34843603 Free PMC article.
Innate immune evasion revealed in a colorectal zebrafish xenograft model.
Póvoa V, Rebelo de Almeida C, Maia-Gil M, Sobral D, Domingues M, Martinez-Lopez M, de Almeida Fuzeta M, Silva C, Grosso AR, Fior R. Póvoa V, et al. Nat Commun. 2021 Feb 19;12(1):1156. doi: 10.1038/s41467-021-21421-y. Nat Commun. 2021. PMID: 33608544 Free PMC article.
Efficacy and safety of pioglitazone in a phase 1/2 imatinib discontinuation trial (EDI-PIO) in chronic myeloid leukemia with deep molecular response.
Pagnano KBB, Lopes ABP, Miranda EC, Delamain MT, Duarte GO, Rodrigues BRV, Povoa VMO, Furlin GCP, Vianna JC, da Silva MAS, De Souza CA, De Paula EV. Pagnano KBB, et al. Among authors: povoa vmo. Am J Hematol. 2020 Dec;95(12):E321-E323. doi: 10.1002/ajh.25986. Epub 2020 Oct 3. Am J Hematol. 2020. PMID: 32864746 Free article. Clinical Trial. No abstract available.
18 results